Beta Glucan Market

Beta glucan is a soluble dietary fiber naturally occurring in the cell walls of oats, barley, certain mushrooms, and yeast, valued for its clinically supported cholesterol-lowering and immune-supporting properties. Extracted and purified into food-grade and supplement-grade ingredients, beta glucan is incorporated into functional foods, beverages, dietary supplements, and select pharmaceutical formulations seeking to leverage its documented physiological benefits.

Demand growth through the 2026-2033 window is closely tied to growing consumer interest in heart health and immune support ingredients, regulatory approval of cholesterol-lowering health claims for oat and barley beta glucan in several major markets, and expanding formulation use across functional food and beverage categories seeking evidence-backed ingredient positioning. Rising consumer scrutiny of ingredient labels is also favoring beta glucan given its natural origin and substantial clinical research base.

The market is valued at USD 1.35 Billion in 2026, with ingredient manufacturers directing investment toward extraction efficiency improvements and expanding yeast-derived beta glucan capacity to serve growing immune health formulation demand. By 2033, the market is forecast to reach USD 2.25 Billion, reflecting sustained growth across established cardiovascular health applications alongside expanding immune health positioning.

• The global beta glucan market is valued at USD 1.35 Billion in 2026 and is projected to reach USD 2.25 Billion by 2033, expanding at a CAGR of 7.6% across the 2026-2033 forecast period.
• Oat & Barley Beta Glucan leads the source segment with a 48.0% share in 2026, equivalent to USD 0.65 Billion.
• Functional Food & Beverages remains the dominant application, accounting for 41.0% of global demand, or USD 0.55 Billion, in 2026.
• North America commands the largest regional share at 33.0% of the global market in 2026.
• Dietary supplement applications are emerging as the fastest-growing demand pocket through 2033.

Growth in the beta glucan market is driven primarily by regulatory approval of cholesterol-lowering health claims for oat and barley beta glucan in several major food markets, which allows manufacturers to make substantiated cardiovascular health claims on product packaging, a significant marketing advantage that has driven sustained formulation adoption across cereal, bakery, and beverage categories.

A second driver is rising consumer interest in immune health support, particularly following heightened general health awareness in recent years, which has increased demand for yeast-derived beta glucan ingredients marketed specifically for their immune-modulating properties in dietary supplement formulations.

The relatively high cost of purified beta glucan ingredients compared with conventional fiber sources limits its use in cost-sensitive food categories, requiring manufacturers to carefully balance the ingredient's health claim benefits against overall formulation cost in price-competitive product segments.

Additionally, achieving effective sensory integration of beta glucan into food and beverage formulations without introducing undesirable texture changes, given its viscosity-increasing properties in aqueous solutions, requires careful formulation expertise that can limit its use in certain product categories without dedicated technical development resources.

The expansion of yeast-derived beta glucan into dietary supplement and immune health formulations presents a substantial opportunity, as this application area continues to grow faster than the market's traditional oat and barley beta glucan base tied to cardiovascular health positioning.

A second opportunity lies in personal care and cosmetic applications, where beta glucan's skin-soothing and moisture-retention properties are gaining formulator interest for use in skincare products, an application area that remains in early development relative to food and supplement uses but offers meaningful diversification potential.

• By Source

Oat & Barley Beta Glucan leads the source segment, accounting for 48.0% of global market value in 2026, equivalent to USD 0.65 Billion. Its leadership reflects established cholesterol-lowering health claim approval and long-standing use in cereal and bakery product formulations. Mushroom Beta Glucan holds a smaller specialized share, primarily used in supplement formulations. Yeast Beta Glucan represents the fastest-growing source category through 2033, driven by rising demand for immune health-positioned supplement ingredients.

• By Application

Functional Food & Beverages forms the leading application segment, representing 41.0% of global demand in 2026, or USD 0.55 Billion, supported by established cardiovascular health claim formulations. Pharmaceuticals and Animal Feed represent steady, established application areas. Dietary Supplements represent the fastest-growing application category, propelled by rising consumer interest in immune health-focused supplementation.

• North America

North America holds the largest regional share, at 33.0% of the global market in 2026, equivalent to USD 0.45 Billion. The region's leadership reflects strong regulatory recognition of beta glucan's cholesterol-lowering benefits alongside an active functional food and dietary supplement product development pipeline.

• Europe

Europe accounts for 30.0% of the global market in 2026, valued at USD 0.41 Billion. Demand is supported by the region's strong regulatory framework recognizing oat and barley beta glucan health claims alongside established functional food manufacturing capacity, particularly in Scandinavian countries with significant oat production.

• Asia Pacific

Asia Pacific represents 25.0% of the global market in 2026, or USD 0.34 Billion. Growth is underpinned by rising health consciousness and expanding functional food and supplement product introductions across China, Japan, and South Korea.

• Latin America

Latin America contributes 7.0% of the global market in 2026, equivalent to USD 0.09 Billion. Growth is linked to gradually expanding functional food and supplement product availability in Brazil and Mexico.

• Middle East & Africa

Middle East & Africa holds 5.0% of the global market in 2026, valued at USD 0.07 Billion. Demand growth remains at an early stage, tied to gradual expansion of functional food and supplement product availability across the region.

The global beta glucan market is moderately fragmented, with a mix of large diversified ingredient companies offering broad functional fiber portfolios and specialized producers focused specifically on oat, yeast, or mushroom-derived beta glucan extraction. Competition centers on extraction purity, clinical research support for health claims, and the ability to provide formulation support across food, beverage, and supplement applications. Producers are increasingly differentiating through source-specific and application-specific beta glucan grades rather than competing on commodity fiber pricing alone.

Key Market Players

• Tate & Lyle PLC
• Kerry Group plc
• dsm-firmenich
• Lantmännen Functional Foods
• Ceapro Inc.
• Biovelop AB
• Garuda International, Inc.
• Associated British Foods plc
• Ohly GmbH
• Angel Yeast Co., Ltd.

By Source

• Oat & Barley Beta Glucan
• Yeast Beta Glucan
• Mushroom Beta Glucan
• Others

By Application

• Functional Food & Beverages
• Dietary Supplements
• Pharmaceuticals
• Animal Feed
• Others

By Form

• Powder Form
• Liquid Form

By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa